DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.

Vanderlinden, Aurelie; Jones, Callum G; Myers, Katie N; Rominiyi, Ola; Collis, Spencer J

Vanderlinden, Aurelie; Jones, Callum G; Myers, Katie N; Rominiyi, Ola; Collis, Spencer J.

Afiliação

Vanderlinden A; Division of Clinical Medicine, The University of Sheffield, School of Medicine and Population Health, Sheffield, S10 2RX, UK.
Jones CG; Division of Clinical Medicine, The University of Sheffield, School of Medicine and Population Health, Sheffield, S10 2RX, UK.
Myers KN; Division of Clinical Medicine, The University of Sheffield, School of Medicine and Population Health, Sheffield, S10 2RX, UK.
Rominiyi O; Division of Clinical Medicine, The University of Sheffield, School of Medicine and Population Health, Sheffield, S10 2RX, UK. o.rominiyi@sheffield.ac.uk.
Collis SJ; Division of Neuroscience, The University of Sheffield, School of Medicine and Population Health, Sheffield, S10 2RX, UK. o.rominiyi@sheffield.ac.uk.

Br J Cancer ; 129(11): 1829-1840, 2023 11.

Article em En | MEDLINE | ID: mdl-37777579

Assuntos

Glioma; Humanos; Glioma/patologia; Reparo do DNA; Dano ao DNA; Mitose

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google